课题基金 / 基金详情

Receptor editing in development T cells

Receptor editing in development T cells
发育T细胞中的受体编辑
批准号:
6979781
负责人:
Kristin A. Hogquist
金额:
$28.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-12-15 至 2007-11-30

项目摘要

项目成果

Kristin A. Hogquist的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by the applicant): An important function of the thymus is to establish self-tolerance in developing T cells. The induction of apoptosis in developing clones that are specific for self-antigen is one mechanism that plays an important role. We recently described another mechanism for self-tolerance, namely receptor editing. Here self-reactive clones undergo gene rearrangement at the TCR alpha locus to produce a new receptor chain that alters the specificity of the clone. This application seeks to understand why clonal deletion occurs in some situations, but receptor editing in others. We will test two variables and determine if each plays a decisive role in the editing versus deletion decision. They are: tissue specificity of antigen presentation and timing of TCR expression during development. We also propose to determine the relative utilization of receptor editing and clonal deletion in the normal (non TCR transgenic) animals, by analysis of the V/J sequences present on excision circles. Finally, we will study the molecular mechanism of receptor editing, specifically testing the hypothesis that TCR ligation drives receptor editing not by inducing a signal for up-regulation of the recombination activating genes (RAG), but by preventing the signal for RAG repression. These issues are central to understanding the developmental biology of T cells. In addition, this topic has important implications for understanding immunologic self-tolerance because the health risks of receptor editing, namely the incidental generation of T cells with two receptor specificities, are quite distinct from those of clonal deletion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
How Cd1d protects mice during natural infection
  • 批准号:
    10307151
  • 项目类别:
  • 资助金额:
    $19.38万
  • 财政年份:
    2020
  • 负责人:
    Kristin A. Hogquist
  • 依托单位:
TCR signal strength in thymic selection
  • 批准号:
    10059163
  • 项目类别:
  • 资助金额:
    $37.2万
  • 财政年份:
    2016
  • 负责人:
    Kristin A. Hogquist
  • 依托单位:
FASEB SRC on Biology of the Immune System
Tolerance to epidermal antigens
  • 批准号:
    8308582
  • 项目类别:
  • 资助金额:
    $33.95万
  • 财政年份:
    2011
  • 负责人:
    Kristin A. Hogquist
  • 依托单位:
国内基金
海外基金
基于prime editing基因编辑小鼠造血干细胞治疗重症联合免疫缺陷的研究
先导编辑技术(prime editing)在双子叶植物中的优化
prime editing基因编辑技术靶向修复MYD88突变治疗华氏巨球蛋白血症的作用及机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    王欣
  • 依托单位:
先导编辑技术(prime editing)在双子叶植物中的优化